GenMont Biotech Inc Working Capital to Net Assets Ratio

Latest as of March 2026: 26.3%

GenMont Biotech Inc working capital to net assets ratio. GenMont Biotech Inc (3164) has a Working Capital to Net Assets ratio of 26.3% as of March 2026. Working capital of NT$369.77 Million (current assets of NT$578.77 Million minus current liabilities of NT$209.00 Million) is measured against net assets of NT$1.41 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of GenMont Biotech Inc to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

26.3%
Working Capital / Net Assets

Working Capital

NT$369.77 Million
TWD

Current Assets

NT$578.77 Million
TWD

Current Liabilities

NT$209.00 Million
TWD

Working Capital to Net Assets Ratio of GenMont Biotech Inc (2004–2025)

Working capital to net assets ratio of GenMont Biotech Inc from 2004 to 2025. This chart shows how GenMont Biotech Inc's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2004 to 2025. As of March 2026, the ratio stands at 26.3%, reflecting working capital of NT$369.77 Million against net assets of NT$1.41 Billion TWD. See 3164 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

GenMont Biotech Inc Working Capital to Net Assets Ratio by Year (2004–2025)

GenMont Biotech Inc working capital to net assets ratio by year from 2004 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for GenMont Biotech Inc from 2004 to 2025, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 3164 asset base.

Year WC/NA Ratio Working Capital (TWD) Net Assets Current Assets Current Liabilities Change (pp)
2025 29.4% NT$425.53 Million NT$1.45 Billion NT$555.31 Million NT$129.78 Million ▲ +2.2 pp
2024 27.1% NT$401.58 Million NT$1.48 Billion NT$541.73 Million NT$140.15 Million ▲ +5.1 pp
2023 22.0% NT$319.12 Million NT$1.45 Billion NT$465.51 Million NT$146.39 Million ▼ -2.1 pp
2022 24.1% NT$360.73 Million NT$1.50 Billion NT$521.50 Million NT$160.78 Million ▼ -4.9 pp
2021 29.0% NT$441.62 Million NT$1.52 Billion NT$580.79 Million NT$139.17 Million ▼ -4.8 pp
2020 33.8% NT$500.98 Million NT$1.48 Billion NT$595.94 Million NT$94.96 Million ▼ -7.3 pp
2019 41.1% NT$595.46 Million NT$1.45 Billion NT$683.76 Million NT$88.31 Million ▼ -24.3 pp
2018 65.4% NT$1.02 Billion NT$1.56 Billion NT$1.11 Billion NT$91.76 Million ▲ +35.9 pp
2017 29.5% NT$404.13 Million NT$1.37 Billion NT$524.05 Million NT$119.92 Million ▲ +2.8 pp
2016 26.7% NT$342.02 Million NT$1.28 Billion NT$454.27 Million NT$112.25 Million ▲ +5.8 pp
2015 20.9% NT$313.43 Million NT$1.50 Billion NT$434.53 Million NT$121.10 Million ▲ +3.4 pp
2014 17.5% NT$279.57 Million NT$1.60 Billion NT$412.15 Million NT$132.58 Million ▼ -61.8 pp
2013 79.3% NT$663.86 Million NT$837.28 Million NT$1.20 Billion NT$535.71 Million ▲ +3.5 pp
2012 75.8% NT$653.00 Million NT$861.62 Million NT$1.22 Billion NT$565.93 Million ▼ -35.0 pp
2011 110.8% NT$1.00 Billion NT$904.75 Million NT$1.11 Billion NT$102.70 Million ▲ +0.0 pp
2010 110.8% NT$817.63 Million NT$737.87 Million NT$945.20 Million NT$127.57 Million ▲ +50.0 pp
2009 60.8% NT$386.65 Million NT$635.68 Million NT$474.96 Million NT$88.30 Million ▼ -8.5 pp
2008 69.3% NT$422.32 Million NT$609.60 Million NT$493.54 Million NT$71.22 Million ▲ +0.4 pp
2007 68.9% NT$361.55 Million NT$524.64 Million NT$408.44 Million NT$46.90 Million ▼ -6.9 pp
2006 75.8% NT$350.18 Million NT$461.75 Million NT$407.59 Million NT$57.41 Million ▲ +27.4 pp
2005 48.4% NT$140.55 Million NT$290.14 Million NT$163.00 Million NT$22.45 Million ▲ +2.5 pp
2004 45.9% NT$135.04 Million NT$294.16 Million NT$149.86 Million NT$14.82 Million —
pp = percentage points